This post was updated March 31 at 11:21 p.m. UCLA researchers developed a human stem cell-derived cell therapy for an aggressive type of breast cancer. This study focused on modifying natural killer T – or NKT – cells, which are a specialized immune cell that quickly responds to cancer cells, according to the National Cancer Institute. Read more...






